229 related articles for article (PubMed ID: 1278717)
1. Altered elimination of antipyrine in patients with acute viral hepatitis.
Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
[TBL] [Abstract][Full Text] [Related]
2. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
Narang AP; Datta DV; Nath N; Mathur VS
Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
[TBL] [Abstract][Full Text] [Related]
4. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
Elin RJ; Vesell ES; Wolff SM
Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
[TBL] [Abstract][Full Text] [Related]
5. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
6. Saliva and plasma clearance of antipyrine as reflectors of liver function.
Luoma PV; Sotaniemi EA
Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
[TBL] [Abstract][Full Text] [Related]
7. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
Breckenridge A; Burke CW; Davies DS; Orme ML
Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
9. Monthly variations in the clearance of antipyrine in the rat.
Bélanger PM; Doré F; Labrecque G
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
[TBL] [Abstract][Full Text] [Related]
10. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine.
Vesell ES; Passananti T; Glenwright PA
Pharmacology; 1975; 13(6):481-91. PubMed ID: 1221431
[TBL] [Abstract][Full Text] [Related]
11. Enflurane anesthesia and antipyrine metabolism.
Duvaldestin P; Mauge F; Desmonts JM
Clin Pharmacol Ther; 1981 Jan; 29(1):61-4. PubMed ID: 7460476
[TBL] [Abstract][Full Text] [Related]
12. Impairment of antipyrine clearance in humans by propranolol.
Greenblatt DJ; Franke K; Huffman DH
Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
[TBL] [Abstract][Full Text] [Related]
13. Liver drug metabolism in patients undergoing open-heart surgery.
Kairaluoma MI; Sotaniemi EA; Mokka RE; Nuutinen L; Kärkölä P; Larmi TK
Scand J Thorac Cardiovasc Surg; 1979; 13(3):281-5. PubMed ID: 542833
[TBL] [Abstract][Full Text] [Related]
14. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum antipyrine half-lives in patients with liver disease.
Branch RA; Herbert CM; Read AE
Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
Harman AE; Priestly BG; Frewin DB
Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
[TBL] [Abstract][Full Text] [Related]
17. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
18. Impairment of drug elimination in patients with liver disease.
Narang AP; Datta DV; Mathur VS
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
[TBL] [Abstract][Full Text] [Related]
19. Influence of alaproclate on antipyrine metabolite formation in man.
Teunissen MW; Wahlén A; Vinnars E; Breimer DD
Eur J Clin Pharmacol; 1984; 27(4):447-52. PubMed ID: 6519152
[TBL] [Abstract][Full Text] [Related]
20. Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice.
McPherson GA; Benjamin IS; Boobis AR; Brodie MJ; Hampden C; Blumgart LH
Gut; 1982 Sep; 23(9):734-8. PubMed ID: 7106619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
